Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine + losartan vs monotherapy in mild to moderate primary hypertension
CTR20160576Phase 2Completed
- Sponsor
- Hanmi Pharmaceutical
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amlodipine besylate + losartan potassium in essential hypertension, sponsored by Hanmi Pharmaceutical. Started Aug 2016; status: completed.
02
Drugs
amlodipine besylate + losartan potassium
03
Conditions
essential hypertension
Beyond the preview
Go deeper on CTR20160576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160576.